Health TrialsbyHealthPanel

A Study Of Starting Strength Barbell Training

ConditionsBlood PressureLipid ProfileFasting Glucose
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-100
SponsorMayo Clinic

About this trial

The purpose of this study is to determine the effect of a 12-week coached Starting Strength barbell training program on systolic and diastolic blood pressure.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18-100 years

Sedentary or minimally active (less than 150 minutes of moderate-intensity physical activity per week)

No participation in structured resistance training programs within the past 6 months.

Able to safely participate in resistance training as determined by medical screening

Disqualifiers

Current participation in structured resistance training programs

Cardiovascular disease requiring activity restriction

Uncontrolled hypertension (systolic BP >180 mm Hg or diastolic BP >110 mm Hg)

Musculoskeletal conditions precluding safe barbell training

Trial design

Design model

Single group

Treatments tested in this trial

  • Progressive Barbell Strength Training

    Other intervention

    Subjects will participate in a 12-week barbell training program, 3 days per week for approximately 60 minutes each session. Training sessions will be conducted by Starting Strength certified coaches at Starting Strength Scottsdale gym. Core barbell movements including but not limited to: squat, deadlift, bench press, overhead press, and power clean.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Starting Strength barbell training programExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in systolic blood pressure

Blood pressure will be measured using automated oscillometric device, and reported in millimeters of mercury (mmHg)

Time frame
Baseline, 16 weeks
2

Change in diastolic blood pressure

Blood pressure will be measured using automated oscillometric device, and reported in millimeters of mercury (mmHg)

Time frame
Baseline, 16 weeks

Secondary outcomes

1

Change in total cholesterol

Total cholesterol is the sum of a person's HDL cholesterol, LDL cholesterol, and 20% of their triglyceride levels. Healthy total cholesterol is less than 200 mg/dL of blood

Time frame
Baseline, 16 weeks
2

Change in low-density lipoprotein cholesterol (LDL-C)

Low-density lipoprotein cholesterol (HDL-C) is measured via blood sample and reported in milligrams per deciliter (mg/DL). Results 100 mg/DL and below are considered healthier.

Time frame
Baseline, 16 weeks
3

Change in high-density lipoprotein cholesterol (HDL-C)

High-density lipoprotein cholesterol (HDL-C) is measured via blood sample and reported in milligrams per deciliter (mg/DL). Results 60 mg/DL and above are considered healthier.

Time frame
Baseline, 16 weeks
4

Change in triglycerides

Triglycerides are measured via blood sample and reported in milligrams per deciliter (mg/DL). Results 150 mg/DL and below are considered normal levels.

Time frame
Baseline, 16 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov
Apply now